newsfilter
← Latest News
Business Wire·

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Virometix AG, a privately held Swiss biotechnology company developing a new generation of fully synthetic vaccines to generate targeted and protective immune responses against infectious diseases and cancer today